OTCs are in Action treating minor symptoms of the Zika virus, which has spread to 66 countries, according to the World Health Organization’s April 21 status report. In fact, the insect-borne disease has become so prevalent that OTC brands are investing in TV advertising detailing their benefits for symptom relief. For example, Nicholas Hall’s OTC INSIGHT Latin America reports this month: GSK’s A+P campaign in support of paracetamol-based Dolex systemic analgesic (known globally as Panadol) highlights its efficacy against symptoms of vector-borne viruses such as zika, chikungunya and dengue.
Nicholas Hall Events will host its 2nd Latin American OTC Conference, From Recession to Recovery: Analysing Latin America’s Return to Growth, on 9-10 June in Miami. Nicholas Hall will be joined by senior professionals with intimate knowledge of the local OTC environment, to offer delegates ways of navigating this dynamic yet unpredictable region.
Following the theme ‘From Recession to Recovery’, our speakers will analyse Latin America’s return to growth showcasing examples of local and global brands, highlighting ways in which they have found success in this region and what lessons can be learned. For more information, please click on the link:
Latin American OTC Conference: From Recession to Recovery